Stephanie Hoang

Stephanie Hoang is a genetic counsellor with Alberta Precision Laboratories and Alberta Health Services. She completed a Bachelors of Science Degree with Honors in Molecular Biology and Genetics at the University of Alberta in 2008 and a Master of Science in Genetic Counselling at the University of British Columbia in 2010. She previously worked in ocular genetics for eight years. She currently works as a laboratory genetic counsellor and is cross appointed to the Medical Genetics Clinic where she practices in general genetics.
Occular genetics, cost utilization of genetic testing, and communication of newborn screen results and laboratory testing.

Selected Publications:

Two-year results after AAV2-mediated gene therapy for choroideremia: the Alberta experience. Dimopoulos IS, Hoang SC, Radziwon A, Binczyk NM, Seabra MC, MacLaren RE, Somani R, Tennant MTS and MacDonald IM. Am J Ophthalmol. 2018 Jun 27;193:130-142.

Pathogenic mechanisms and the prospect of gene therapy for choroideremia. Dimopoulos IS, Chan S, MacLaren RE, MacDonald IM. Expert Opin Orphan Drugs. 2015 Jul 1;3(7):787-798.

Choroideremia. MacDonald IM, Hume S, Chan S, et al. 2003 Feb 21 [Updated 2015 Feb 26]. In: Pagon RA, Adam MP, Amemiya A, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2015. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1337/

X-linked juvenile retinoschisis. Sieving PA, MacDonald IM, Chan S. 2003 Oct 24 [Updated 2014 Aug 28]. In: Pagon RA, Adam MP, Amemiya A, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2015. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1222/

A centralized approach to out-of-province genetic testing leads to cost savings: The Alberta experience. Lilley M, Christian S, Blumenschein P, Chan S, Somerville M. Clin Genet 2013 Oct;84(4):373-7.